The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Berman Mark A. since 2023.
This trader's CIK number is 1890348.
At the time of last reporting, Berman Mark A. was the Chief Medical Officer of Better Therapeutics, Inc.. (stock ticker symbol BTTX).
Also see all insider trading activities at Better Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | BTTX | 54,802 | $40,005 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-27 | BTTX | Buy | 54,802 | .73 | 40,005 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berman Mark A. (Chief Medical Officer of Better Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.